September 07, 2016
Boom in unproven cell therapies intensifies regulatory debate
news@nature.com - Fetched: September 7th, 2016, 8:00am UTC
Controversial US guidelines attempt to rein in rogue stem-cell clinics.
Nature 537 148 doi: 10.1038/537148a